Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States
Jessica E Hawley,Tianyi Sun,David D Chism,Narjust Duma,Julie C Fu,Na Tosha N Gatson,Sanjay Mishra,Ryan H Nguyen,Sonya A Reid,Oscar K Serrano,Sunny R K Singh,Neeta K Venepalli,Ziad Bakouny,Babar Bashir,Mehmet A Bilen,Paolo F Caimi,Toni K Choueiri,Scott J Dawsey,Leslie A Fecher,Daniel B Flora,Christopher R Friese,Michael J Glover,Cyndi J Gonzalez,Sharad Goyal,Thorvardur R Halfdanarson,Dawn L Hershman,Hina Khan,Chris Labaki,Mark A Lewis,Rana R McKay,Ian Messing,Nathan A Pennell,Matthew Puc,Deepak Ravindranathan,Terence D Rhodes,Andrea V Rivera,John Roller,Gary K Schwartz,Sumit A Shah,Justin A Shaya,Mitrianna Streckfuss,Michael A Thompson,Elizabeth M Wulff-Burchfield,Zhuoer Xie,Peter Paul Yu,Jeremy L Warner,Dimpy P Shah,Benjamin French,Clara Hwang,COVID-19 and Cancer Consortium (CCC19),Balazs Halmos,Amit K Verma,Benjamin A Gartrell,Sanjay Goel,Nitin Ohri,R Alejandro Sica,Astha Thakkar,Keith E Stockerl-Goldstein,Omar Butt,Jian L Campian,Mark A Fiala,Jeffrey P Henderson,Ryan Monahan,Alice Y Zhou,Pamela Bohachek,Daniel Mundt,Eyob Tadesse,Philip E Lammers,Orestis A Panagiotou,Pamela C Egan,Dimitrios Farmakiotis,Adam J Olszewski,Arturo Loaiza-Bonilla,Salvatore A Del Prete,Michael H Bar,Anthony P Gulati,K M Steve Lo,Suzanne J Rose,Jamie Stratton,Paul L Weinstein,Jill S Barnholtz-Sloan,Jorge A Garcia,John M Nakayama,Shilpa Gupta,Manmeet S Ahluwalia,Christopher A Lemmon,Amanda Nizam,Claire Hoppenot,Ang Li,Gabrielle Bouchard,Fiona J Busser,Jean M Connors,Catherine R Curran,George D Demetri,Antonio Giordano,Kaitlin Kelleher,Anju Nohria,Andrew Schmidt,Grace Shaw,Eli Van Allen,Pier Vitale,Vincent Xu,Rebecca L Zon,Tian Zhang,Susan Halabi,John C Leighton Jr,Gary H Lyman,Jerome J Graber,Petros Grivas,Ali Raza Khaki,Elizabeth T Loggers,Ryan C Lynch,Elizabeth S Nakasone,Michael T Schweizer,Lisa Tachiki,Shaveta Vinayak,Michael J Wagner,Albert Yeh,Minh-Phuong Huynh-Le,Lori J Rosenstein,Jessica M Clement,Ahmad Daher,Mark Dailey,Rawad Elias,Asha Jayaraj,Emily Hsu,Alvaro G Menendez,Joerg Rathmann,Oscar Serrano,Shirish M Gadgeel,Dawn Hershman,Melissa K Accordino,Divaya Bhutani,Daniel Y Reuben,Mariam Alexander,Sarah Mushtaq,Eric H Bernicker,John Deeken,Danielle Shafer,David M Gill,Clarke A Low,Sandeep H Mashru,Abdul-Hai Mansoor,Howard A Zaren,Stephanie J Smith,Gayathri Nagaraj,Mojtaba Akhtari,Eric Lau,Mark E Reeves,Stephanie Berg,Destry Elms,Alicia K Morgans,Firas H Wehbe,Jessica Altman,Michael Gurley,Mary F Mulcahy,Eric B Durbin,Amit A Kulkarni,Heather H Nelson,Zohar Sachs,Surbhi Shah,Rachel P Rosovsky,Kerry Reynolds,Aditya Bardia,Genevieve Boland,Justin Gainor,Leyre Zubiri,Tanios Bekaii-Saab,Aakash Desai,Ruben A Mesa,Mark Bonnen,Daruka Mahadevan,Amelie G Ramirez,Mary Salazar,Pankil K Shah,Bryan Faller,Archana Ajmera,Sharon S Brouha,Angelo Cabal,Albert Hsiao,Seth Kligerman,Lisa B Weissmann,Chinmay Jani,Carey C Thomson,Jeanna Knoble,Mary Grace Glace,Cameron Rink,Karen Stauffer,Rosemary Zacks,Sibel Blau,Monika Joshi,Harry Menon,Marc A Rovito,Elizabeth A Griffiths,Amro Elshoury,Salma K Jabbour,Christian F Misdary,Mansi R Shah,Christopher McNair,Sana Z Mahmood,Vasil Mico,Andrea Verghese Rivera,Barbara B Logan,Goetz Kloecker,Chaitanya Mandapakala,Elwyn C Cabebe,Alokkumar Jha,Lidia Schapira,Julie Tsu-Yu Wu,Suki Subbiah,Gilberto de Lima Lopes Jr,Sanjay G Revankar,Daniel G Stover,Daniel Addison,James L Chen,Margaret E Gatti-Mays,Sachin R Jhawar,Vidhya Karivedu,Maryam B Lustberg,Joshua D Palmer,Sarah Wall,Nicole Williams,Elizabeth Wulff-Burchfield,Anup Kasi,Natasha Edwin,Melissa Smits,Susie Owenby,Deborah B Doroshow,Matthew D Galsky,Michael Wotman,Huili Zhu,Alyson Fazio,Mark H Sueyoshi,Kathryn E Huber,Jonathan Riess,Kanishka G Patel,Samuel M Rubinstein,William A Wood,Christopher Jensen,Vaibhav Kumar,Trisha M Wise-Draper,Syed A Ahmad,Punita Grover,Shuchi Gulati,Jordan Kharofa,Tahir Latif,Michelle Marcum,Cathleen Park,Hira G Shaikh,Daniel W Bowles,Christoper L Geiger,Merry-Jennifer Markham,Rohit Bishnoi,Atlantis D Russ,Chintan Shah,Jared D Acoba,Young Soo Rho,Lawrence E Feldman,Kent F Hoskins,Gerald Gantt Jr,Li C Liu,Mahir Khan,Mary Pasquinelli,Candice Schwartz,Praveen Vikas,Blanche H Mavromatis,Ragneel R Bijjula,Qamar U Zaman,Alex Cheng,Elizabeth J Davis,Stephany N Duda,Kyle T Enriquez,Erin A Gillaspie,Cassandra Hennessy,Daniel Hausrath,Chih-Yuan Hsu,Douglas B Johnson,Xuanyi Li,Brian I Rini,David A Slosky,Yu Shyr,Carmen C Solorzano,Matthew D Tucker,Karen Vega-Luna,Lucy L Wang,Hagen F Kennecke,David M Aboulafia,Brett A Schroeder,Theresa M Carducci,Karen J Goldsmith,Susan Van Loon,Umit Topaloglu,Saif I Alimohamed,Robert L Rice,Wilhelmina D Cabalona,Christine Pilar,Prakash Peddi,Lane R Rosen,Briana Barrow McCollough,Navid Hafez,Roy Herbst,Patricia LoRusso,Tyler Masters,Catherine Stratton
DOI: https://doi.org/10.1001/jamanetworkopen.2021.42046
2022-01-04
Abstract:Importance: The COVID-19 pandemic has had a distinct spatiotemporal pattern in the United States. Patients with cancer are at higher risk of severe complications from COVID-19, but it is not well known whether COVID-19 outcomes in this patient population were associated with geography. Objective: To quantify spatiotemporal variation in COVID-19 outcomes among patients with cancer. Design, setting, and participants: This registry-based retrospective cohort study included patients with a historical diagnosis of invasive malignant neoplasm and laboratory-confirmed SARS-CoV-2 infection between March and November 2020. Data were collected from cancer care delivery centers in the United States. Exposures: Patient residence was categorized into 9 US census divisions. Cancer center characteristics included academic or community classification, rural-urban continuum code (RUCC), and social vulnerability index. Main outcomes and measures: The primary outcome was 30-day all-cause mortality. The secondary composite outcome consisted of receipt of mechanical ventilation, intensive care unit admission, and all-cause death. Multilevel mixed-effects models estimated associations of center-level and census division-level exposures with outcomes after adjustment for patient-level risk factors and quantified variation in adjusted outcomes across centers, census divisions, and calendar time. Results: Data for 4749 patients (median [IQR] age, 66 [56-76] years; 2439 [51.4%] female individuals, 1079 [22.7%] non-Hispanic Black individuals, and 690 [14.5%] Hispanic individuals) were reported from 83 centers in the Northeast (1564 patients [32.9%]), Midwest (1638 [34.5%]), South (894 [18.8%]), and West (653 [13.8%]). After adjustment for patient characteristics, including month of COVID-19 diagnosis, estimated 30-day mortality rates ranged from 5.2% to 26.6% across centers. Patients from centers located in metropolitan areas with population less than 250 000 (RUCC 3) had lower odds of 30-day mortality compared with patients from centers in metropolitan areas with population at least 1 million (RUCC 1) (adjusted odds ratio [aOR], 0.31; 95% CI, 0.11-0.84). The type of center was not significantly associated with primary or secondary outcomes. There were no statistically significant differences in outcome rates across the 9 census divisions, but adjusted mortality rates significantly improved over time (eg, September to November vs March to May: aOR, 0.32; 95% CI, 0.17-0.58). Conclusions and relevance: In this registry-based cohort study, significant differences in COVID-19 outcomes across US census divisions were not observed. However, substantial heterogeneity in COVID-19 outcomes across cancer care delivery centers was found. Attention to implementing standardized guidelines for the care of patients with cancer and COVID-19 could improve outcomes for these vulnerable patients.